Get the Stockscreener App
1.49
0.68%
0.01
After Hours:
1.46
-0.03
-2.01%
Cardiol Therapeutics Inc stock is traded at $1.49, with a volume of 596.81K.
It is up +0.68% in the last 24 hours and up +9.56% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.48
Open:
$1.48
24h Volume:
596.81K
Relative Volume:
2.40
Market Cap:
$123.15M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-4.4866
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
+6.43%
1M Performance:
+9.56%
6M Performance:
+5.67%
1Y Performance:
-31.02%
1-Day Range:
$1.45
$1.55
1-Week Range:
$1.36
$1.59
52-Week Range:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.49 | 122.32M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Real time alert setup for Cardiol Therapeutics Inc. performanceFree Fast Gaining Stock Screener Report - Newser
Is Cardiol Therapeutics Inc. a growth stock or a value stockFree Stock Alerts For Every Investor - jammulinksnews.com
Is Cardiol Therapeutics Inc. stock overvalued or undervaluedMarket Forecast Picks That Work - jammulinksnews.com
What is Cardiol Therapeutics Inc. company’s growth strategyBest Dividend Ideas For Beginners - jammulinksnews.com
Chart based analysis of Cardiol Therapeutics Inc. trendsStep-by-Step Stock Investment Guide Gains Popularity - metal.it
What technical models suggest about Cardiol Therapeutics Inc.’s comebackLong-Term Stock Growth Forecast Insights - Newser
How to use a screener to detect Cardiol Therapeutics Inc. breakoutsFree Watchlist for Low Risk High Return - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis toolsFree Low Capital High Return Stock Plans - Newser
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsAI Screener for Daily Stock Forecast - Newser
Institutional scanner results for Cardiol Therapeutics Inc.High Return Strategy with Low Risk - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityTechnical Trend Forecast for Investors - Newser
New Product Launches: Will They Boost Cardiol Therapeutics Inc. Stock in 2025Weekly Top Gainers Forecast Watchlist Released - metal.it
Will Cardiol Therapeutics Inc. rebound enough to break evenConsistent Gain Plan with AI Support - Newser
Using Bollinger Bands to evaluate Cardiol Therapeutics Inc.Real Time Stock Movement and Alerts - Newser
Is It Too Late to Sell Cardiol Therapeutics Inc.Weekly Watchlist of High Movers Released - beatles.ru
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionConsistent Income Focused Trade List Analyzed - beatles.ru
Are Bears Losing Grip on Cardiol Therapeutics Inc.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
What makes Cardiol Therapeutics Inc. stock price move sharplyMulti-Year Investment Performance Summary Report - Newser
Visualizing Cardiol Therapeutics Inc. stock with heatmapsAI Powered Stock Market Trend Forecast - Newser
Real time alert setup for Cardiol Therapeutics Inc. performance Entry Confirmation Based on Volatility Analysis - Newser
How to integrate Cardiol Therapeutics Inc. into portfolio analysis tools Watchlist Generator for Smart Money Signals - Newser
Why is Cardiol Therapeutics Inc. stock attracting strong analyst attentionGame-changing capital returns - jammulinksnews.com
When is Cardiol Therapeutics Inc. stock expected to show significant growthAccelerate your capital gains today - jammulinksnews.com
How does Cardiol Therapeutics Inc. compare to its industry peersDiscover stocks with strong growth potential - jammulinksnews.com
Moving Average Trends for Cardiol Therapeutics Inc. Stock: What They IndicateReal Trader Insights - Newser
Is Cardiol Therapeutics Inc. Stock a Good Fit for Conservative InvestorsHigh Potential Shares - Newser
Published on: 2025-07-27 15:05:27 - jammulinksnews.com
How strong is Cardiol Therapeutics Inc. company’s balance sheetMaximize your portfolio’s earning potential - jammulinksnews.com
What drives Cardiol Therapeutics Inc. stock priceFree Stock Selection - PrintWeekIndia
Does Cardiol Therapeutics Inc. stock pay reliable dividendsSkyrocketing profit margins - jammulinksnews.com
How high can Cardiol Therapeutics Inc. stock price go in 2025Rapidly expanding wealth - jammulinksnews.com
Is Cardiol Therapeutics Inc. stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):